January 31, 2020

Congratulations to Mammoth Biosciences for raising $45M Series B, led by Decheng Capital and new investor Verily→

January 31, 2020/ Jack Liang

Mammoth Biosciences today announced a $45M Series B to develop the next generation of CRISPR products and help to tackle Coronavirus.